ClinicalTrials.gov record
Completed Phase 2 Interventional

A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

ClinicalTrials.gov ID: NCT01844180

Public ClinicalTrials.gov record NCT01844180. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 4:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

Study identification

NCT ID
NCT01844180
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Ono Pharma USA Inc
Industry
Enrollment
200 participants

Conditions and interventions

Interventions

  • ONO-2952 Drug
  • ONO-2952 Matching Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2013
Primary completion
Jun 30, 2014
Completion
Not listed
Last update posted
Apr 14, 2016

Started 2013

United States locations

U.S. sites
48
U.S. states
22
U.S. cities
48
Facility City State ZIP Site status
Anniston Clinical Site Anniston Alabama 36207
Goodyear Clinical Site Goodyear Arizona 85351
Tucson Clinical Site Tucson Arizona 85712
North Little Rock Clinical Site North Little Rock Arkansas 72120
Carlsbad Clinical Site Carlsbad California 92008
San Diego Clinical Site San Diego California 92114
Boynton Beach Clinical Site Boynton Beach Florida 33426
Clearwater Clinical Site Clearwater Florida 33756
Deland Clinical Site DeLand Florida 32720
Hialeah Clinical Site Hialeah Florida 33012
Lauderdale Lakes Clinical Site Lauderdale Lakes Florida 33319
Orlando Clinical Site Orlando Florida 32806
Port Orange Clinical Site Port Orange Florida 32129
South Miami Clinical Site South Miami Florida 33143
St. Petersburg Clinical Site St. Petersburg Florida 33709
Tampa Clinical Site Tampa Florida 33606
West Palm Clinical Site West Palm Florida 33409
Oak Lawn Clinical Site Oak Lawn Illinois 60453
Wichita Clinical Site Wichita Kansas 67203
New Orleans Clinical Site New Orleans Louisiana 70115
Chesterfield Clincial Site Chesterfield Michigan 48047
Billings Clinical Site Billings Montana 59102
Reno Clinical Site Reno Nevada 89511
Lebanon Clinical Site Lebanon New Hampshire 03756
Albuquerque Clinical Site Albuquerque New Mexico 87102
Great Neck Clinical Site Great Neck New York 11023
Cary Clinical Site Cary North Carolina 27518
Highpoint Clinical Site Highpoint North Carolina 27262
Raleigh Clinical Site Raleigh North Carolina 27612
Winston-Salem Clinical Site Winston-Salem North Carolina 27103
Akron Clinical Site Akron Ohio 44311
Columbus Clinical Site Columbus Ohio 43212
Dayton Clinical Site Dayton Ohio 45432
Groveport Clinical Site Groveport Ohio 43125
Mentor Clinical Site Mentor Ohio 44060
Norman Clinical Site Norman Oklahoma 73069
Lansdale Clinical Site Landsdale Pennsylvania 19446
Greer Clinical Site Greer South Carolina 29650
Mt. Pleasant Clinical Site Mt. Pleasant South Carolina 29464
Chattanooga Clinical Site Chattanooga Tennessee 37421
Germantown Clinical Site Germantown Tennessee 38138
Pasadena Clinical Site Pasadena Texas 77505
Plano Clinial Site Plano Texas 75075
San Antonio Clinical Site San Antonio Texas 78229
Logan Clinical Site Logan Utah 84341
Ogden Clinical Site Ogden Utah 84405
Salt Lake City Clinical Site Salt Lake City Utah 84107
Sandy Clinical Site Sandy City Utah 84094

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01844180, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 14, 2016 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01844180 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →